Advertisement

Related Videos

Mark Sculpher, PhD: How Do We Assess the Value of Cancer Drug Optimization?

Javid J. Moslehi, MD, on Cardiovascular and Thrombotic Considerations of Kinase Inhibitors: The Case of BTK Inhibitors

Focus on Optimized Dosing of Ibrutinib Panel Discussion

Garth Strohbehn, MD, MPhil, on Applied Clinical Pharmacology in a Crisis: Interventional Pharmacoeconomics and COVID-19

Robin Feldman, JD: Are Dubious Patents a Large or Small Issue?

Advertisement

Advertisement




Mar
12
Today In Oncology
Can Viral Respiratory Infections Increase Lung Cancer Risk
Female Reproductive Cancers Linked to Reduced Survival Advantage Over Males
Early Study Evaluates Two-Vaccine Strategy in T-Cell Lymphoma
Structured Exercise Plan for Patients With Cancer May Reduce Cognitive Effects of Chemotherapy
Risk of Breast Cancer After Ovarian Cancer in Women With BRCA1/2 Variants
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo